Matthew John Kolar, MD
Dermatology · San Diego
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
Offices
4 locations · Regents of the University of California · 2,047 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kolar’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$6,019
Medicare paid this office $6,019 for 37 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 12 | $933 | $78 |
| Destruction of precancer skin growth, 1 growth | 14 | $658 | $47 |
| Destruction of precancer skin growth, 2-14 growths | 11 | $320 | $6 |
Procedures Medicare counted
| Removal of skin lesions | 149 | More than 78% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 24 | More than 64% of doctors who do this |
Who their Medicare patients are
37 Original Medicare patients in 2024. Average age 74 · Women 51% · Health risk score 1.89. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 59%.
The office billed $29,806, Medicare allowed $7,560 and paid $6,019; for 122 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
$13,433
Pharmacies billed $13,433 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 86) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
71 generic and 15 brand-name prescriptions · $13,433 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tacrolimus | 12 | $1,254 | $105 |
| Ketoconazole | 22 | $338 | $15 |
| Triamcinolone Acetonide | 15 | $295 | $20 |
Year by year
| 2024 | 86 | 40 | 0% (0) | 17% | $13,433 |
| 2023 | 213 | 89 | 0% (0) | 6% | $36,620 |
| 2022 | 223 | 103 | 0% (0) | 8% | $100,276 |
| 2021 | 47 | 31 | 0% (0) | None | $2,211 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Fluorouracil | 11 | $1,174 | $107 |
| Doxycycline Hyclate | 30 | $572 | $19 |
| Ketoconazole | 27 | $391 | $14 |
| Clindamycin Phosphate | 22 | $364 | $17 |
| Triamcinolone Acetonide | 13 | $185 | $14 |
2022: 7 drugs
| Clobetasol Propionate | 13 | $1,490 | $115 |
| Fluorouracil | 13 | $1,269 | $98 |
| Betamethasone Dipropionate | 12 | $830 | $69 |
| Ketoconazole | 30 | $737 | $25 |
| Triamcinolone Acetonide | 28 | $498 | $18 |
| Clindamycin Phosphate | 20 | $364 | $18 |
| Hydrocortisone | 14 | $143 | $10 |
Money from drug and device companies
$396 in 2025
| 2025 | 2 | 3 | None | $396 |
| 2024 | 2 | 2 | None | $223 |
| 2023 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Galderma Laboratories L.P. | Nemluvio | $250 | 2 payments
|
| Genzyme | Dupixent | $146 | 1 payment
|
See all 3 published payments
| Galderma Laboratories L.P. | Meals · 2025-12-16 | Nemluvio | $144 |
| Genzyme | Meals · 2025-05-06 | Dupixent | $146 |
| Galderma Laboratories L.P. | Meals · 2025-04-30 | Nemluvio | $106 |
See earlier years (2024, 2023)
2024: $223
| Abbvie | Rinvoq | $124 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $98 | 1 payment
|
2023: $23
| Pfizer | Eucrisa | $23 | 1 payment
|
Professional record
- NPI
- 1164050167
- Licence
- CA 1164050167
- Trained
- University of California, San Diego School of Medicine, 2020
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Student in a training program (390200000X)
- Mailing address
- File 57326, Los Angeles, CA, 90074
- NPI first listed
- 2020-03-27
- NPI last updated
- 2024-06-24
- NPI record certified
- 2024-06-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 8899 University Center Ln, San Diego, CA, 92122 · 8899 University Center Ln Ste 350, San Diego, CA, 92122 · 751 S Bascom Ave, San Jose, CA, 95128